18 June 2013
Keywords: avandia, does, raise, cv, risk, relative, antidiabetics
Article | 09 June 2009
A large study of Avandia (rosiglitazone), sponsored by UK drug major GlaxoSmithKline in a bid to dispel safety concerns surrounding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2009
5 June 2009
17 June 2013
© 2013 thepharmaletter.com